4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-20-020161
Exec. VP, European Commercial sold 616 shares at $7.17 ($4,418)
- Exec. VP, European Commercial acquired 1,297 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Daniell Richard Exec. VP, European Commercial | 2020-03-17 | Option exercise | +1,297 | 11,016 | D: show line 1 in the form | ||
| Daniell Richard Exec. VP, European Commercial | 2020-03-17 | Sale | −616 | $7.17 | $4,418 | 10,400 | D: show line 2 in the form |
| Open-market sales · 616 sh · avg $7.17 · $4,418 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Daniell Richard Exec. VP, European Commercial | 2020-03-17 | Option exercise · Restricted Share Units | −1,297 | 0 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…